Company Avalon GloboCare Corp.

Equities

ALBT

US05344R2031

Healthcare Facilities & Services

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Sector Medical & Diagnostic Laboratories

Market Closed - Nasdaq Other stock markets 02:00:00 11/05/2024 am IST			5-day change	1st Jan Change
0.34 ^USD	+22.43%		+37.88%	-29.61%

22/04	Avalon GloboCare Corp. Announces Launch of U.S. Sales of KetoAir Breathalyzer at the Hack Your Health by KetoCon 2024 Conference	CI
17/04	North American Morning Briefing : Stock Futures -2-	DJ

Avalon GloboCare Corp. is a commercial-stage company engaged in developing and delivering transformative, precision diagnostics and clinical laboratory services. The Company offers diagnostic testing utilizing proprietary technology to deliver genetics-driven results. It operates through two segments: Real property rental and Lab Services MSO. Lab Services MSO segment is focused on delivering services related to toxicology and wellness testing and provides a portfolio of diagnostic tests including drug testing, toxicology, and a range of test services, from general bloodwork to anatomic pathology, and urine toxicology. Its capabilities include STAT blood testing, qualitative drug screening, genetic testing, urinary testing, and sexually transmitted disease testing. The Lab Services MSO segment is also focused on the commercialization of genetic-based proprietary testing. It is also exploring the commercialization and development of a versatile breathalyzer system, KetoAir breathalyzer.

Number of employees: 5

USD in Million	2022	Weight	2023	Weight	Delta
Real Property 100.0 %	1	100.0 %	1	100.0 %	+4.45%

USD in Million	2022	Weight	2023	Weight	Delta
United States 100.0 %	1	100.0 %	1	100.0 %	+4.45%

Managers	Title	Age	Since
David Jin CEO	Chief Executive Officer	56	14/16/14
Luisa Ingargiola DFI	Director of Finance/CFO	56	01/07/01
Meng Li SAM	Sales & Marketing	46	10/16/10

Members of the board	Title	Age	Since
Steven Sanders BRD	Director/Board Member	78	31/18/31
Billy Tauzin BRD	Director/Board Member	81	07/17/07
William Stilley BRD	Director/Board Member	56	05/18/05
Lourdes Felix BRD	Director/Board Member	56	09/23/09
David Jin CEO	Chief Executive Officer	56	14/16/14
Meng Li SAM	Sales & Marketing	46	10/16/10
Wen Zhao Lu CHM	Chairman	66	10/16/10
Tevi Troy BRD	Director/Board Member	56	04/18/04

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	0	11,000	0	0	43.80 %
Stock B	1	11,156,534	4,887,100 ( 43.80 %)	52,000 ( 0.4661 %)
Stock C	0	9,000	0	0

Name	Equities	%	Valuation
Wen Zhao Lu 32.58 %	3,583,788	32.58 %	1 M $
David Jin 14.05 %	1,545,000	14.05 %	494 400 $
Fsunshine Trading Pte Ltd. 5.215 %	573,646	5.215 %	183 567 $
Meng Li 4.682 %	515,000	4.682 %	164 800 $
Vanguard Group, Inc. (Subfiler) 0.3137 %	34,504	0.3137 %	11 041 $
Geode Capital Management LLC 0.1857 %	20,424	0.1857 %	6 536 $
STATE STREET CORPORATION 0.1738 %	19,120	0.1738 %	6 118 $
Two Sigma Securities LLC 0.1309 %	14,393	0.1309 %	4 606 $
Millennium Management LLC 0.1149 %	12,636	0.1149 %	4 044 $
Virtu Financial LLC 0.1110 %	12,211	0.1110 %	3 908 $

Avalon GloboCare Corp.

4400 Route 9 South Suite 3100

07728, Freehold

+732 780 4400

http://www.avalon-globocare.com

Healthcare

Healthcare Services

Healthcare Providers & Services

Healthcare Facilities & Services

Medical & Diagnostic Laboratories

	1st Jan change	Capi.
AVALON GLOBOCARE CORP.	-29.61%	3.78M
SONIC HEALTHCARE LIMITED	-16.58%	8.49B
RADNET, INC.	+58.90%	4.08B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-39.78%	2.42B
SYNLAB AG	-10.33%	2.42B
DR. LAL PATHLABS LIMITED	-8.91%	2.33B
NEOGENOMICS, INC.	-2.53%	2.01B
FLEURY S.A.	-19.90%	1.53B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-38.30%	1.26B
METROPOLIS HEALTHCARE LIMITED	+2.19%	1.07B

Medical & Diagnostic Laboratories